Terms: = Gastric cancer AND SALL4, ENSG00000101115, 57167, Q9UJQ4, ZNF797, MGC133050, HSAL4, DRRS, dJ1112F19_1 AND Treatment
14852 results:
1. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
[TBL] [Abstract] [Full Text] [Related]
2. The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.
Li JB; Lai MY; Lin ZC; Guan WL; Sun YT; Yang J; Wang WX; Yang ZR; Qiu MZ
Cancer Immunol Immunother; 2024 May; 73(7):132. PubMed ID: 38753055
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced gastric cancer.
Yamaguchi K; Ito M; Isobe T; Koreishi S; Taguchi R; Uehara K; Ueno S; Imajima T; Kitazono T; Tsuchihashi K; Ohmura H; Yoshihiro T; Tanoue K; Nishiyori S; Iwama E; Maeda T; Akashi K; Baba E
JCO Precis Oncol; 2024 May; 8():e2300681. PubMed ID: 38748981
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
5. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
[TBL] [Abstract] [Full Text] [Related]
7. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
8. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
9. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
[TBL] [Abstract] [Full Text] [Related]
10. Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer.
Liu Y; Chen W; Ruan R; Zhang Z; Wang Z; Guan T; Lin Q; Tang W; Deng J; Wang Z; Li G
J Transl Med; 2024 May; 22(1):438. PubMed ID: 38720336
[TBL] [Abstract] [Full Text] [Related]
11. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract] [Full Text] [Related]
12. Effects of perioperative low-dose naloxone on the immune system in patients undergoing laparoscopic-assisted total gastrectomy: a randomized controlled trial.
Min X; Ma Y; Leng Y; Li X; Zhang J; Xu S; Wang X; Lv R; Guo J; Xing H
BMC Anesthesiol; 2024 May; 24(1):172. PubMed ID: 38720250
[TBL] [Abstract] [Full Text] [Related]
13. Predicting Helicobacter pylori infection from endoscopic features.
Seo JY; Ahn JY; Kim S; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Korean J Intern Med; 2024 May; 39(3):439-447. PubMed ID: 38715232
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
Zhang P; Chen Z; Shi S; Li Z; Ye F; Song L; Zhang Y; Yin F; Zhang X; Xu J; Cheng Y; Su W; Shi M; Fan S; Tan P; Zhong C; Lu M; Shen L
Cancer Immunol Immunother; 2024 May; 73(7):119. PubMed ID: 38713205
[TBL] [Abstract] [Full Text] [Related]
15. Is there any difference between Eastern and Western clinical practice guidelines in management of gastric cancer?
Jalaeefar A; Mousavi SZ; Shirkhoda M; Mahmoodzadeh H; Mohammadzadeh N; Sharifi A
Cancer Rep (Hoboken); 2024 May; 7(5):e2076. PubMed ID: 38711281
[TBL] [Abstract] [Full Text] [Related]
16. Metastasis to the stomach: a systematic review.
Ibrahimli A; Aliyev A; Majidli A; Kahraman A; Galandarova A; Khalilzade E; Mammadli H; Huseynli K; Assaf K; Kilinc C; Muradov N; Alisan OF; Abdullayev S; Sahin YI; Samadov E
F1000Res; 2023; 12():1374. PubMed ID: 38706640
[No Abstract] [Full Text] [Related]
17. Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.
Ligumsky H; Amir S; Arbel Rubinstein T; Guion K; Scherf T; Karasik A; Wolf I; Rubinek T
Med Oncol; 2024 May; 41(6):138. PubMed ID: 38705935
[TBL] [Abstract] [Full Text] [Related]
18. Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for paclitaxel treatment.
Yu P; Hu C; Ding G; Shi X; Xu J; Cao Y; Chen X; Wu W; Xu Q; Fang J; Huang X; Yuan S; Chen H; Wang Z; Huang L; Pang F; Du Y; Cheng X
Nat Commun; 2024 May; 15(1):3771. PubMed ID: 38704377
[TBL] [Abstract] [Full Text] [Related]
19. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
[TBL] [Abstract] [Full Text] [Related]
20. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.
Ding W; Chen L; Xia J; Pei B; Song B; Li X
Medicine (Baltimore); 2024 May; 103(18):e38010. PubMed ID: 38701318
[TBL] [Abstract] [Full Text] [Related]
[Next]
